The present invention relates to compounds that are sodium channel inhibitors and to their use in the treatment of various disease states, including cardiovascular diseases and diabetes. In particular embodiments, the structure of the compounds is given by Formula I:wherein W1, W2, W3, R1, Q, X1, X2and X3are as described herein, to methods for the preparation and use of the compounds and to pharmaceutical compositions containing the same.本發明係有關鈉通道抑制劑之化合物且有關其治療各種病況之用途,包括心血管疾病及糖尿病,亦有關製備該等化合物之方法及用途且有關含有該等化合物之醫藥組成物。特定具體實施態樣中,化合物結構係表示為式I:其中W1、W2、W3、R1、Q、X1、X2及X3係如此處所述。